BioSpace News Archive

Innovative Neulasta® Onpro® Kit is Designed to Provide the Right Dose for Patients at the Right Time

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast.

Feb. 27, 2018 14:17 UTC Applied Health Analytics Launches bMetrix to Automate Biometric Data Collection, Reduce Errors at Point-of-Care Health Screening Events NASHVILLE, Tenn.--( BUSINESS WIRE )-- Applied Health Analytics, LLC has launched bMetrix™, a proprietary screening application that automates the collection of biometric data, allowing for clinicians and wellness screeners to accurately gather information at onsite and retail c

Invicro, LLC, a Konica Minolta company and a leading provider of imaging services and software for research and drug development, today announced the hiring of Mr. Edward Hogan, M.S. as Senior Vice President of Clinical Operations. Mr. Hogan brings extensive medical imaging and clinical research experience that will significantly advance Invicro’s clinical imaging core lab capabilities across all stages of the drug development pipeline (Phase I-IV).

Omega Healthcare - a leading provider of Revenue Cycle Management and analytics solutions to US-based hospitals and medical billing companies, including Fortune 100 companies - has been ranked amongst the top 2 in ‘Market Impact’ and ‘Vision & Capability’, in the global Healthcare BPO Service Provider Market Assessment - 2017, by the Everest Group.

Appointment of Raphaël Darteil as VP Non-Clinical Development & Product Profiling; EYP001 study 103 in chronic HBV patients set to deliver results in Q2 2018; Two Phase IIa studies with EYP001 in CHBV and in NASH to start in H2 2018

PixarBio Corporation clarifies their early 2016 decision to terminate the US FDA Orphan Drug Designation application process for treating Trigeminal Neuralgia.

New Website Features its Robust Beyond Human® Sales & Marketing Platform

Amarantus BioScience Holdings, Inc. (OTCPK: AMBS) (the “Company” or AMBS), a US-based biotechnology holding company with wholly-owned subsidiaries...

Inogen, Inc. reported financial results for the three-month and twelve-month periods ended December 31, 2017.